This inventor holds 70 USPTO granted patents and 17 published patent applications, plus 10 CIPO patents and 22 EPO patents, primarily in Pharmaceutical Chemistry (CPC class C07D). Top assignees: Abbott Gmbh & Co Kg, Basf Aktiengesellschaft, Abbvie Deutschland Gmbh and Co Kg. Active years: 1996-2018.
Inventors with similar research interests:
Location History:
- Oberursel, DE (1996)
- Westboro, MA (US) (1999)
- Northborough, MA (US) (1999 - 2006)
- Westborough, MA (US) (1998 - 2008)
- Schweizingen, DE (2014)
- Schwetzingen, DE (1999 - 2015)
- Wiesbaden, DE (2016)
- Ludwigshafen, DE (1996 - 2018)
Company Filing History:
37 out of 140 
17 out of 10,754 
14 out of 167 
Years Active: 1996-2018
Areas of Expertise:
Title: Andreas Haupt: Innovator in Pharmaceutical Chemistry
Introduction: Andreas Haupt, an accomplished inventor residing in Schwetzingen, Germany, has made significant contributions to the field of pharmaceutical chemistry. With an impressive portfolio of 70 patents to his name, Haupt has established himself as a prominent figure in the world of innovation, particularly in the development of compounds that modulate the 5-HT receptor.
Latest Patents: Among his latest patents, Haupt has developed quinoline compounds that are crucial for pharmaceutical compositions aimed at treating various conditions and disorders tied to the modulation of the 5-HT receptor. These inventions encompass methods for preparing medicaments that target specific health issues effectively. Additionally, he has been involved in creating tricyclic quinoline and quinoxaline derivatives, which further expand the therapeutic options available for medication preparation, specifically focusing on their roles as modulators of the 5-HT receptor.
Career Highlights: Throughout his career, Andreas Haupt has contributed to esteemed companies such as Abbott GmbH & Co. KG and BASF Aktiengesellschaft. His work in these organizations has been instrumental in advancing pharmaceutical research and innovation. His ability to translate complex chemical formulas into viable medicinal applications underscores his status as a leading inventor in his field.
Collaborations: Haupt has collaborated with notable colleagues, including Karla Drescher and Liliane Unger, enhancing the innovative potential of their combined expertise. These collaborations have not only fostered a dynamic working environment but have also led to groundbreaking developments in pharmacology and medicinal chemistry.
Conclusion: Andreas Haupt's dedication to innovation in pharmaceutical chemistry is reflected in his substantial patent portfolio and collaborative efforts. His work continues to have a profound impact on the development of new medications that address critical health issues, positioning him as a key player in the field of healthcare innovation.